Literature DB >> 22285015

The genetics of dyskeratosis congenita.

Philip J Mason1, Monica Bessler.   

Abstract

Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome associated with characteristic mucocutaneous features and a variable series of other somatic abnormalities. The disease is heterogeneous at the genetic and clinical levels. Determination of the genetic basis of DC has established that the disease is caused by a number of genes, all of which encode products involved in telomere maintenance, either as part of telomerase or as part of the shelterin complex that caps and protects telomeres. There is overlap at the genetic and clinical levels with other, more common conditions, including aplastic anemia (AA), pulmonary fibrosis (PF), and liver cirrhosis. Although part of the spectrum of disorders known to be associated with DC, it has emerged that mutations in telomere maintenance genes can lead to the development of AA and PF in the absence of other DC features. Here we discuss the genetics of DC and its relationship to disease presentation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22285015      PMCID: PMC3269008          DOI: 10.1016/j.cancergen.2011.11.002

Source DB:  PubMed          Journal:  Cancer Genet


  109 in total

1.  A telomerase component is defective in the human disease dyskeratosis congenita.

Authors:  J R Mitchell; E Wood; K Collins
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

Review 2.  A critical role for telomeres in suppressing and facilitating carcinogenesis.

Authors:  S E Artandi; R A DePinho
Journal:  Curr Opin Genet Dev       Date:  2000-02       Impact factor: 5.578

Review 3.  Dyskeratosis congenita in all its forms.

Authors:  I Dokal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

Review 4.  Telomeres and telomerase in cancer.

Authors:  Steven E Artandi; Ronald A DePinho
Journal:  Carcinogenesis       Date:  2009-11-03       Impact factor: 4.944

Review 5.  Alternative lengthening of telomeres: models, mechanisms and implications.

Authors:  Anthony J Cesare; Roger R Reddel
Journal:  Nat Rev Genet       Date:  2010-03-30       Impact factor: 53.242

6.  Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1.

Authors:  S W Knight; N S Heiss; T J Vulliamy; C M Aalfs; C McMahon; P Richmond; A Jones; R C Hennekam; A Poustka; P J Mason; I Dokal
Journal:  Br J Haematol       Date:  1999-11       Impact factor: 6.998

Review 7.  Box H/ACA small ribonucleoproteins.

Authors:  Tamás Kiss; Eléonore Fayet-Lebaron; Beáta E Jády
Journal:  Mol Cell       Date:  2010-03-12       Impact factor: 17.970

8.  Targeted next-generation sequencing appoints c16orf57 as clericuzio-type poikiloderma with neutropenia gene.

Authors:  Ludovica Volpi; Gaia Roversi; Elisa Adele Colombo; Nico Leijsten; Daniela Concolino; Andrea Calabria; Maria Antonietta Mencarelli; Michele Fimiani; Fabio Macciardi; Rolph Pfundt; Eric F P M Schoenmakers; Lidia Larizza
Journal:  Am J Hum Genet       Date:  2009-12-10       Impact factor: 11.025

9.  Effects of dyskeratosis congenita mutations in dyskerin, NHP2 and NOP10 on assembly of H/ACA pre-RNPs.

Authors:  Christian Trahan; Caroline Martel; François Dragon
Journal:  Hum Mol Genet       Date:  2009-12-15       Impact factor: 6.150

10.  Zscan4 regulates telomere elongation and genomic stability in ES cells.

Authors:  Michal Zalzman; Geppino Falco; Lioudmila V Sharova; Akira Nishiyama; Marshall Thomas; Sung-Lim Lee; Carole A Stagg; Hien G Hoang; Hsih-Te Yang; Fred E Indig; Robert P Wersto; Minoru S H Ko
Journal:  Nature       Date:  2010-03-24       Impact factor: 49.962

View more
  54 in total

Review 1.  Understanding telomere diseases through analysis of patient-derived iPS cells.

Authors:  Luis F Z Batista; Steven E Artandi
Journal:  Curr Opin Genet Dev       Date:  2013-08-28       Impact factor: 5.578

2.  CTC1 Mutations in a patient with dyskeratosis congenita.

Authors:  Rachel B Keller; Katelyn E Gagne; G Naheed Usmani; George K Asdourian; David A Williams; Inga Hofmann; Suneet Agarwal
Journal:  Pediatr Blood Cancer       Date:  2012-04-24       Impact factor: 3.167

3.  Dyskeratosis congenita caused by a novel TERT point mutation in siblings with pancytopenia and exudative retinopathy.

Authors:  Akshay Sharma; Kasiani Myers; Zhan Ye; John D'Orazio
Journal:  Pediatr Blood Cancer       Date:  2014-07-25       Impact factor: 3.167

4.  Mechanism of the AAA+ ATPases pontin and reptin in the biogenesis of H/ACA RNPs.

Authors:  Rosario Machado-Pinilla; Dominique Liger; Nicolas Leulliot; U Thomas Meier
Journal:  RNA       Date:  2012-08-24       Impact factor: 4.942

5.  A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia.

Authors:  Jonathan A Kropski; Daphne B Mitchell; Cheryl Markin; Vasiliy V Polosukhin; Leena Choi; Joyce E Johnson; William E Lawson; John A Phillips; Joy D Cogan; Timothy S Blackwell; James E Loyd
Journal:  Chest       Date:  2014-07       Impact factor: 9.410

6.  Quality control of assembly-defective U1 snRNAs by decapping and 5'-to-3' exonucleolytic digestion.

Authors:  Siddharth Shukla; Roy Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

7.  Liver failure due to hepatic angiosarcoma in an adolescent with dyskeratosis congenita.

Authors:  Timothy S Olson; Elaine S Chan; Michele E Paessler; Kathleen E Sullivan; Christopher N Frantz; Piere Russo; Monica Bessler
Journal:  J Pediatr Hematol Oncol       Date:  2014-05       Impact factor: 1.289

Review 8.  The shelterin complex and hematopoiesis.

Authors:  Morgan Jones; Kamlesh Bisht; Sharon A Savage; Jayakrishnan Nandakumar; Catherine E Keegan; Ivan Maillard
Journal:  J Clin Invest       Date:  2016-05-02       Impact factor: 14.808

9.  Multiple genetic pathways regulate replicative senescence in telomerase-deficient yeast.

Authors:  Bari J Ballew; Victoria Lundblad
Journal:  Aging Cell       Date:  2013-06-28       Impact factor: 9.304

Review 10.  The inherited bone marrow failure syndromes.

Authors:  S Deborah Chirnomas; Gary M Kupfer
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.